| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 20-F | 20-F | 20-F | 20-F | 20-F |
| Revenues: |
| AI Solutions | 0.3 | 0.3 | | | |
| Radiology Services | 8.2 | 1.0 | | | |
| Total revenues | 0.3 | 1.3 | 69.1 | 38.8 | 0.0 |
| Revenue growth [+] | -79.3% | -98.1% | 77.9% | | |
| AI Solutions | 27.0% | | | | |
| Radiology Services | 696.4% | | | | |
| Cost of goods sold | 15.5 | 2.8 | 0.0 | 0.0 | 0.0 |
| Gross profit | -15.2 | -1.5 | 69.1 | 38.8 | 0.0 |
| Gross margin | -5625.2% | -116.0% | 100.0% | 100.0% | |
| Selling, general and administrative [+] | 59.3 | 57.2 | 56.1 | 35.4 | 1.2 |
| Sales and marketing | 5.4 | 9.5 | 21.7 | 2.2 | 0.2 |
| General and administrative | 54.0 | 47.8 | 34.4 | 33.3 | 1.0 |
| Research and development | 26.5 | 17.2 | 9.6 | 2.7 | 0.7 |
| Other operating expenses | -39.0 | -17.7 | 43.9 | 22.6 | |
| EBITDA [+] | -50.5 | -56.0 | -40.3 | -21.9 | -1.9 |
| EBITDA growth | -9.8% | 38.9% | 84.5% | 1069.4% | |
| EBITDA margin | -18708.9% | -4295.9% | -58.4% | -56.3% | |
| Depreciation | 0.9 | 0.5 | 0.2 | 0.1 | 0.0 |
| EBITA | -51.4 | -56.5 | -40.5 | -21.9 | -1.9 |
| EBITA margin | -19044.1% | -4336.0% | -58.7% | -56.4% | |
| Amortization of intangibles | 10.6 | 1.8 | | | |
| EBIT [+] | -62.0 | -58.3 | -40.5 | -21.9 | -1.9 |
| EBIT growth | 6.4% | 43.8% | 85.0% | 1050.7% | |
| EBIT margin | -22972.6% | -4471.6% | -58.7% | -56.4% | |
| Non-recurring items [+] | 55.7 | 3.2 | 3.4 | 0.7 | |
| Asset impairment | 50.9 | | | | |
| Interest income, net [+] | 0.8 | -0.3 | 0.1 | 0.0 | |
| Interest expense | | 0.3 | | | |
| Interest income | 0.8 | | 0.1 | 0.0 | |
| Other income (expense), net [+] | | | | | 0.0 |
| Change in fair value of warrants | -20.4 | | | | |
| Other | 8.2 | 1.2 | | | |
| Pre-tax income | -116.9 | -61.8 | -43.8 | -22.6 | -1.9 |
| Income taxes | -3.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 3.1% | 0.1% | 0.0% | 0.0% | 0.0% |
| Earnings from continuing ops | -113.2 | -61.8 | | -22.6 | -1.9 |
| Earnings from discontinued ops | | | -43.8 | | |
| Net income | -113.2 | -61.8 | -43.8 | -22.6 | -1.9 |
| Net margin | -41941.9% | -4739.1% | -63.4% | -58.1% | |
| |
| Basic EPS [+] | ($2.17) | ($1.28) | $0.00 | ($0.90) | ($0.09) |
| Growth | 69.1% | | -100.0% | 876.0% | |
| Diluted EPS [+] | ($2.17) | ($1.28) | $0.00 | ($0.90) | ($0.09) |
| Growth | 69.1% | | -100.0% | 876.0% | |
| |
| Dividends per share [+] | $0.00 | $0.00 | | | |
| Growth | 539.0% | | | | |
| |
| Shares outstanding (basic) [+] | 52.2 | 48.2 | 35.7 | 25.2 | 20.8 |
| Growth | 8.3% | 35.2% | 41.6% | 21.1% | |
| Shares outstanding (diluted) [+] | 52.2 | 48.2 | 35.7 | 25.2 | 20.8 |
| Growth | 8.3% | 35.2% | 41.6% | 21.1% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |